Updated:
Merck Animal Health
Merck Animal Health operates within the animal health sector, providing veterinary medicines and services. Its products target disease prevention, treatment,...
Merck Animal Health
Merck Animal Health operates within the animal health sector, providing veterinary medicines and services. Its products target disease prevention, treatment, and control in farm and companion animals. The company serves animal health professionals, producers, and equine owners, with a history dating back to 1921 and a base in Madison, New Jersey.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Madison
Corporate office
Madison, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Merck Animal Health?
Merck Animal Health is a division of Merck & Co., so strategic and R&D investment decisions are made by the parent company's executive team and the division's leadership. The division does not disclose a named CEO or CIO publicly. Funding for new product development and regulatory approvals flows from Merck's corporate balance sheet (per Merck & Co. filings).
What investment stages does Merck Animal Health typically target?
Merck Animal Health does not target investment stages—it is a product-development organization. Its R&D pipeline spans preclinical to FDA approval stages for veterinary drugs and vaccines. Recent approvals include late-stage clinical development of NUMELVI™ for dogs (per FDA, February 2026) and Circumvent® CL for pigs (per company, December 2025).
Which sectors does Merck Animal Health explicitly avoid?
Merck Animal Health avoids human pharmaceuticals, medical devices for humans, and any animal health areas outside its core species portfolio (cattle, swine, poultry, companion animals, and aquaculture). It does not invest in veterinary services clinics, pet insurance, or animal health software platforms.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: